Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Alopecia is a condition of partial or complete hair loss in an individual. Alopecia may begin with hair loss on the scalp, either in patches or on the entire head. The onset of this disease is often random, sudden, and recurrent.

Asia Pacific alopecia treatment market is estimated to account for US$ 4,060.9 Mn in terms of value and is expected to reach US$ 6,427.7 Mn by the end of 2027.

Asia Pacific Alopecia Treatment Market: Drivers

Increasing prevalence of alopecia is expected to propel growth of the Asia Pacific alopecia market over the forecast period. For instance, according to a 2019 survey released by the China Association of Health Promotion and Education (CAHEP), one out of six Chinese people, or about 250 million people, are suffering from hair loss.

Moreover, increasing geriatric population is also expected to aid in growth of the market. For instance, according to United Nations Population Fund, geriatric population in Asia Pacific is expected to triple between 2010 and 2050 to reach 1.3 billion people by 2050.s 

Alopecia Areata held dominant position in Asia Pacific alopecia treatment market in 2019, accounting for 65.8% share in terms of value, followed by Alopecia Totalis and Alopecia Universalis, respectively

Figure 1. Asia Pacific Alopecia Treatment Market Share (%), by Value, by Indication, 2019

Asia Pacific Alopecia Treatment  | Coherent Market Insights

Asia Pacific Alopecia Treatment Market: Restraints

Limited efficacy and lack of evidences suggesting clinical efficacy of available hair loss drugs is hampering growth of the market. For instance, current topical hair loss treatments available in the market such as minoxidil are not 100% effective in treating alopecia, although it has been clinically proven to slow down the progression of hair loss.

Moreover, lack of reimbursement for hair loss treatments services is also expected to limit the market growth. Both public and private payers do not reimburse most of the laser treatment services. The pricing of such services varies widely and there cannot be any standardization.

request-sample

Asia Pacific Alopecia Treatment Market Report Coverage

Report Coverage Details
Base Year: 2019 Market Size in 2019: US$ 1,903.9 Mn
Historical Data for: 2016 to 2019 Forecast Period: 2020 to 2027
Forecast Period 2020 to 2027 CAGR: 6.8% 2027 Value Projection: US$ 3,214.8 Mn
Geographies covered:
  • Asia Pacific: China, India, Japan, Australia, New Zealand, Malaysia, Singapore, Vietnam, Philippines, Rest of Asia Pacific
Segments covered:
  • By Treatment Type:
    • Topical Drugs: Creams, Oils, Gels, Shampoo, Lotion, Foam.
    • Oral Drugs
    • Injectables: Platelet Rich Plasma, Steroid Injections, Injectable Filler.
    • Hair Transplant Services
    • Low-Level Laser Therapy
  • By Disease Indication: Alopecia Areata, Alopecia Totalis, Alopecia Universalis.
  • By End User: Hospitals, Dermatologic and Trichology Clinics, Home care settings, Aesthetic Clinics.
Companies covered:

Teva Pharmaceutical Industries Ltd., Merck & Co., Inc., Johnson & Johnson, Inc., Pfizer, Inc., Dr. Reddy’s Laboratories Ltd., Cipla Ltd., Cellmid Ltd., The Himalaya Drug Company, Taisho Pharmaceutical Holdings Co., Ltd., Shiseido Co., Ltd., Concert Pharmaceuticals, Inc., Follica, Inc., REVIAN Inc., Incyte, Eli Lilly and Company, Histogen, Inc., and Zhangguang 101 Science & Technology Co., Ltd.

Growth Drivers:
  • Increasing prevalence of alopecia
  • People perception towards having good aesthetics
Restraints & Challenges:
  • Lack of evidence supporting efficacy of available drugs

Asia Pacific Alopecia Treatment Market: Opportunities 

Adoption of platelet-rich plasma therapy is expected to offer lucrative growth opportunities for players in Asia Pacific alopecia treatment market. For instance, in April 2020, researchers from Plastic and Reconstructive Surgery, “Tor Vergata” University, Italy, reported that platelet-rich plasma may considered as a safe and effective alternative procedure to treat hair loss compared with Minoxidil and Finasteride.

Moreover, adoption of nanotechnology is also expected to aid in growth of the market. For instance, in March 2020, researchers from University of Coimbra, Portugal, reviewed the potential of nanotechnology-based topical minoxidil delivery formulations for improved hair loss therapeutics.

Asia Pacific alopecia treatment market was valued at US$ 2,030.5 Mn in 2019 and is forecast to reach a value of US$ 3,214.8 Mn by 2027 at a CAGR of 6.8% between 2020 and 2027.

Figure 2. Asia Pacific Alopecia Treatment Market Value (US$ Mn), and Y-o-Y Growth (%), 2019-2027

Asia Pacific Alopecia Treatment  | Coherent Market Insights

Market Trends/Key Takeaways

Major players in the market are focused on conducting clinical trials for the treatment of alopecia. For instance, in June 2020, Follica, Inc. announced positive feedback from a meeting with the U.S. Food and Drug Administration (FDA) for its lead program to treat male androgenetic alopecia.

Increasing prevalence of alopecia among young people is boosting growth of the market. For instance, according to a report conducted by AliHealth, a private health arm of Alibaba Group, in 2019, around 36% of the hair-loss population is post-90s.

Regulations:

India:

Drugs and Cosmetics Act, 1940 governs the provisions relating to manufacture, sale, storage, distribution, and import of drugs as well as cosmetics products in India.

China:

Ministry of Health, Regulations on Cosmetics Hygiene Supervision, (MOH) Regulation: This regulation is formulated to strengthen hygiene supervision over cosmetics so as to ensure hygiene quality and safety of use and to safeguard consumer health.

Asia Pacific Alopecia Market: Competitive Landscape

Major players operating in Asia Pacific alopecia market include, Teva Pharmaceutical Industries Ltd., Merck & Co., Inc., Johnson & Johnson, Inc., Pfizer, Inc., Dr. Reddy’s Laboratories Ltd., Cipla Ltd., Cellmid Ltd., The Himalaya Drug Company, Taisho Pharmaceutical Holdings Co., Ltd., Shiseido Co., Ltd., Concert Pharmaceuticals, Inc., Follica, Inc., REVIAN Inc., Incyte, Eli Lilly and Company, Histogen, Inc., and Zhangguang 101 Science & Technology Co., Ltd.

Asia Pacific Alopecia Market: Key Developments

Major players in the market are focused on R&D to expand their product portfolio. For instance, in June 2020, Histogen, Inc. enrolled the first patient in its Phase 1b/2a clinical trial of HST 001, the company’s lead therapeutic candidate for the treatment of androgenic alopecia in men.

Major players in the market are focused on approval and launch of new products to expand their product portfolio. For instance, in March 2020, Incyte and Eli Lilly and Company received the U.S. FDA’s Breakthrough Therapy Designation for baricitinib for the treatment of alopecia areata.

Alopecia areata is a common autoimmune disorder that results in unpredictable hair loss. Alopecia is the common autoimmune disorder, which causes hair loss or sometimes it may lead to baldness. Cicatricial alopecia is the condition characterized by hair loss accompanied by the formation of scars. Alopecia is classified into alopecia areata, androgenic alopecia, alopecia totalis, and cicatricial alopecia. In this case, the body attacks its own anagen hair follicles and suppresses or stops hair growth.  

Restraints of the Asia Pacific Alopecia Treatment Market

Major factors hampering the growth of the Asia Pacific alopecia treatment market during the forecast period constitutes of limited efficacy and lack of evidences suggesting clinical efficacy of available hair loss drugs.

Key features of the study:

  • This report provides in-depth analysis of the Asia pacific alopecia treatment market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2019–2027), considering 2018, as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
  • It profiles leading players in the Asia pacific alopecia treatment market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Teva Pharmaceutical Industries Ltd., Merck & Co., Inc., Johnson & Johnson, Inc., Pfizer, Inc., Dr. Reddy’s Laboratories Ltd., Cipla Ltd., Cellmid Ltd., The Himalaya Drug Company, Taisho Pharmaceutical Holdings Co., Ltd., Shiseido Co., Ltd., Concert Pharmaceuticals, Inc., Follica, Inc., REVIAN Inc., Incyte, Eli Lilly and Company, Histogen, Inc., and Zhangguang 101 Science & Technology Co., Ltd.
  • Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
  • The Asia pacific alopecia treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.

Detailed Segmentation

  • Asia Pacific Alopecia Treatment Market, By Treatment Type:
    • Topical Drugs
      • Creams
      • Oils
      • Gels
      • Shampoo
      • Lotion
      • Foam
    • Oral Drugs
    • Injectables
      • Platelet Rich Plasma
      • Steroid Injections
      • Injectable Filler
    • Hair Transplant Services
    • Low-Level Laser Therapy
  • Asia Pacific Alopecia Treatment Market, By Disease Indication:
    • Alopecia Areata
    • Alopecia Totalis
    • Alopecia Universalis
  • Asia Pacific Alopecia Treatment Market, By End User:
    • Hospitals
    • Dermatologic and Trichology Clinics
    • Home care settings
    • Aesthetic Clinics
  • Asia Pacific Alopecia Treatment Market, By Countries:
    • China
      • By Treatment Type
        • Topical Drugs
          • Creams
          • Oils
          • Gels
          • Shampoo
          • Lotion
          • Foam
        • Oral Drugs
        • Injectables
          • Platelet Rich Plasma
          • Steroid Injections
          • Injectable Filler
        • Hair Transplant Services
        • Low-Level Laser Therapy
      • By Disease Indication:
        • Alopecia Areata
        • Alopecia Totalis
        • Alopecia Universalis
      • By End User
        • Hospitals
        • Dermatologic and Trichology Clinics
        • Home care settings
        • Aesthetic Clinics
    • Japan
      • By Treatment Type
        • Topical Drugs
          • Creams
          • Oils
          • Gels
          • Shampoo
          • Lotion
          • Foam
        • Oral Drugs
        • Injectables
          • Platelet Rich Plasma
          • Steroid Injections
          • Injectable Filler
        • Hair Transplant Services
        • Low-Level Laser Therapy
      • By Disease Indication:
        • Alopecia Areata
        • Alopecia Totalis
        • Alopecia Universalis
      • By End User
        • Hospitals
        • Dermatologic and Trichology Clinics
        • Home care settings
        • Aesthetic Clinics
    • Australia
      • By Treatment Type
        • Topical Drugs
          • Creams
          • Oils
          • Gels
          • Shampoo
          • Lotion
          • Foam
        • Oral Drugs
        • Injectables
          • Platelet Rich Plasma
          • Steroid Injections
          • Injectable Filler
        • Hair Transplant Services
        • Low-Level Laser Therapy
      • By Disease Indication:
        • Alopecia Areata
        • Alopecia Totalis
        • Alopecia Universalis
      • By End User
        • Hospitals
        • Dermatologic and Trichology Clinics
        • Home care settings
        • Aesthetic Clinics
    • India
      • By Treatment Type
        • Topical Drugs
          • Creams
          • Oils
          • Gels
          • Shampoo
          • Lotion
          • Foam
        • Oral Drugs
        • Injectables
          • Platelet Rich Plasma
          • Steroid Injections
          • Injectable Filler
        • Hair Transplant Services
        • Low-Level Laser Therapy
      • By Disease Indication:
        • Alopecia Areata
        • Alopecia Totalis
        • Alopecia Universalis
      • By End User
        • Hospitals
        • Dermatologic and Trichology Clinics
        • Home care settings
        • Aesthetic Clinics
    • Malaysia
      • By Treatment Type
        • Topical Drugs
          • Creams
          • Oils
          • Gels
          • Shampoo
          • Lotion
          • Foam
        • Oral Drugs
        • Injectables
          • Platelet Rich Plasma
          • Steroid Injections
          • Injectable Filler
        • Hair Transplant Services
        • Low-Level Laser Therapy
      • By Disease Indication:
        • Alopecia Areata
        • Alopecia Totalis
        • Alopecia Universalis
      • By End User
        • Hospitals
        • Dermatologic and Trichology Clinics
        • Home care settings
        • Aesthetic Clinics
    • Singapore
      • By Treatment Type
        • Topical Drugs
          • Creams
          • Oils
          • Gels
          • Shampoo
          • Lotion
          • Foam
        • Oral Drugs
        • Injectables
          • Platelet Rich Plasma
          • Steroid Injections
          • Injectable Filler
        • Hair Transplant Services
        • Low-Level Laser Therapy
      • By Disease Indication:
        • Alopecia Areata
        • Alopecia Totalis
        • Alopecia Universalis
      • By End User
        • Hospitals
        • Dermatologic and Trichology Clinics
        • Home care settings
        • Aesthetic Clinics
    • Vietnam
      • By Treatment Type
        • Topical Drugs
          • Creams
          • Oils
          • Gels
          • Shampoo
          • Lotion
          • Foam
        • Oral Drugs
        • Injectables
          • Platelet Rich Plasma
          • Steroid Injections
          • Injectable Filler
        • Hair Transplant Services
        • Low-Level Laser Therapy
      • By Disease Indication:
        • Alopecia Areata
        • Alopecia Totalis
        • Alopecia Universalis
      • By End User
        • Hospitals
        • Dermatologic and Trichology Clinics
        • Home care settings
        • Aesthetic Clinics
    • Philippines
      • By Treatment Type
        • Topical Drugs
          • Creams
          • Oils
          • Gels
          • Shampoo
          • Lotion
          • Foam
        • Oral Drugs
        • Injectables
          • Platelet Rich Plasma
          • Steroid Injections
          • Injectable Filler
        • Hair Transplant Services
        • Low-Level Laser Therapy
      • By Disease Indication:
        • Alopecia Areata
        • Alopecia Totalis
        • Alopecia Universalis
      • By End User
        • Hospitals
        • Dermatologic and Trichology Clinics
        • Home care settings
        • Aesthetic Clinics
    • Rest of APAC
      • By Treatment Type
        • Topical Drugs
          • Creams
          • Oils
          • Gels
          • Shampoo
          • Lotion
          • Foam
        • Oral Drugs
        • Injectables
          • Platelet Rich Plasma
          • Steroid Injections
          • Injectable Filler
        • Hair Transplant Services
        • Low-Level Laser Therapy
      • By Disease Indication:
        • Alopecia Areata
        • Alopecia Totalis
        • Alopecia Universalis
      • By End User
        • Hospitals
        • Dermatologic and Trichology Clinics
        • Home care settings
        • Aesthetic Clinics
  • Company Profiles
    • Teva Pharmaceutical Industries Ltd.*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Strategies
      • Recent Developments
    • Merck & Co., Inc.
    • Johnson & Johnson, Inc.
    • Pfizer, Inc.
    • Dr. Reddy’s Laboratories Ltd.
    • Cipla Ltd.
    • Cellmid Ltd.
    • The Himalaya Drug Company
    • Taisho Pharmaceutical Holdings Co. Ltd.
    • Shiseido Co., Ltd.
    • Other Major Players

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objective and Assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Treatment Type
      • Market Snippet, By Disease Indication
      • Market Snippet, By End User
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Key Developments
    • Technological Advancement
    • Regulatory Scenario
    • Impact of COVID-19 Analysis
  4. Asia Pacific Alopecia Treatment Market, By Treatment Type, 2017 – 2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2019–2027
      • Segment Trends
    • Topical Drugs
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
      • Segment Trends
        • Creams
        • Oils
        • Gels
        • Shampoo
        • Lotion
        • Foam
    • Oral Drugs
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
      • Segment Trends
    • Injectables
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
      • Segment Trends
        • Platelet Rich Plasma
        • Steroid Injections
        • Injectable Filler
    • Hair Transplant Services
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
      • Segment Trends
    • Low-Level Laser Therapy
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
      • Segment Trends
  5. Asia Pacific Alopecia Treatment Market, By Disease Indication, 2017 – 2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2019–2027
      • Segment Trends
    • Alopecia Areata
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
      • Segment Trends
    • Alopecia Totalis
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
      • Segment Trends
    • Alopecia Universalis
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
      • Segment Trends
  6. Asia Pacific Alopecia Treatment Market, By End User, 2017 – 2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2019–2027
      • Segment Trends
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
      • Segment Trends
    • Dermatologic and Trichology Clinics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
      • Segment Trends
    • Home care settings
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
      • Segment Trends
    • Aesthetic Clinics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
      • Segment Trends
  7. Asia Pacific Alopecia Treatment Market, By Countries, 2017 – 2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2019–2027
      • Segment Trends
    • China
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
    • Japan
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
    • Australia
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
    • India
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
    • Malaysia
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
    • Singapore
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
    • Vietnam
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
    • Philippines
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
    • Rest of APAC
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
  8. Competitive Landscape
    • Company Profiles
      • Teva Pharmaceutical Industries Ltd.
        • Company Overview
        • Treatment Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Merck & Co., Inc.
        • Company Overview
        • Treatment Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Johnson & Johnson, Inc.
        • Company Overview
        • Treatment Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Pfizer, Inc.
        • Company Overview
        • Treatment Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Dr. Reddy’s Laboratories Ltd.
        • Company Overview
        • Treatment Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Cipla Ltd.
        • Company Overview
        • Treatment Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Cellmid Ltd.
        • Company Overview
        • Treatment Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • The Himalaya Drug Company
        • Company Overview
        • Treatment Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Taisho Pharmaceutical Holdings Co. Ltd.
        • Company Overview
        • Treatment Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Shiseido Co., Ltd.
        • Company Overview
        • Treatment Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Other Major Players
        • Company Overview
        • Treatment Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
  9. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 31 market data tables and 28 figures on “Alopecia Treatment Market – Asia Pacific forecast to 2027”.

Frequently Asked Questions

Asia Pacific alopecia treatment market was valued at US$ 2,030.5 Mn in 2019 and is forecast to reach a value of US$ 3,214.8 Mn by 2027 at a CAGR of 6.8% between 2020 and 2027.
Major factor driving the growth of global Asia Pacific alopecia treatment market during the forecast period include increasing prevalence of alopecia, and people perception towards having good aesthetics.
Major factors hampering the growth of the Asia Pacific alopecia treatment market during the forecast period constitutes of limited efficacy and lack of evidences suggesting clinical efficacy of available hair loss drugs.
Oral drugs held dominant position in the Asia Pacific alopecia treatment market in 2019.
China alopecia treatment market is expected to generate the highest revenue during the forecast period.
Some of the key players operating in the market are Teva Pharmaceutical Industries Ltd., Merck & Co., Inc., Johnson & Johnson, Inc., Pfizer, Inc., Dr. Reddy’s Laboratories Ltd., Cipla Ltd., Cellmid Ltd., The Himalaya Drug Company, Taisho Pharmaceutical Holdings Co., Ltd., Shiseido Co., Ltd., Concert Pharmaceuticals, Inc., Follica, Inc., REVIAN Inc., Incyte, Eli Lilly and Company, Histogen, Inc., and Zhangguang 101 Science & Technology Co., Ltd.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner